Willow vs Trimi: Tracking-Focused Care vs Low-Cost Compounds
Quick verdict: Willow positions itself as a telehealth-first oral GLP-1 weight management program that emphasizes progress tracking and follow-up support, starting at 299, while Trimi focuses on compounded semaglutide and tirzepatide with flat pricing as low as 99/month and free overnight shipping. Choose Willow if you want structured digital follow-up; choose Trimi if you prioritize lower starting prices and fast shipping.
Explore Willow’s tracked program
Willow vs Trimi: core approach and program model
Willow frames its offering as an oral GLP-1 weight management journey with wellness tracking, follow-up consultations, and a licensed telehealth team. Trimi offers compounded semaglutide and tirzepatide prescribed by US-licensed clinicians and shipped from FDA regulated pharmacies, with pricing that starts as low as 99/month on the annual plan and free overnight, temperature-controlled shipping. Both operate via telehealth and require clinician review; Willow emphasizes structured behavioral support, while Trimi emphasizes medication access, flat pricing, and shipping speed.
Key difference 1: Pricing
Willow lists a starting price of 299. Trimi advertises compounded semaglutide from 99/month on the annual plan and tirzepatide at 125/month, with the explicit claim that the price remains the same as dose increases. Trimi also highlights a 6-month money-back promise under specified terms. Pricing details, membership, and renewal terms for both may vary and should be confirmed before enrollment.
Key difference 2: Medication format and regulatory notes
Willow promotes oral GLP-1 as part of a tracked program. Trimi prescribes compounded semaglutide and tirzepatide prepared by state-licensed compounding pharmacies. Both sources state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Willow notes treatment is available only when a licensed clinician determines it is medically appropriate. Trimi details clinician oversight via Arora Health and named 503A compounding pharmacies with certificates of analysis available on request.
Key difference 3: Support and follow-up
Willow highlights progress tracking tools and follow-up consultations as central features, positioning its model as structured digital follow-up to convert medication effects into longer-term outcomes. Trimi advertises clinician visits, ongoing check-ins, and that one flat membership can cover medication, clinician visits, and shipping, but emphasizes its flat pricing and logistics features more than behavioral tracking.
Key difference 4: Shipping, refunds, and logistics
Trimi specifies free overnight, temperature-controlled shipping and an automatic refund if not approved by their medical team, plus a 6-month money-back promise with terms. Willow’s captured page did not verify shipping, refund, membership, or cancellation details. Where logistics matter, Trimi supplies more explicit shipping and refund claims in the captured evidence.
| Criteria | Willow | Trimi |
|---|---|---|
| Starting price | 299 | Semaglutide from 99/month; tirzepatide 125/month (annual plan) |
| Medication type | Oral GLP-1 program | Compounded semaglutide and tirzepatide |
| Support model | Progress tracking tools; follow-up consultations; licensed telehealth team | Clinician visits, ongoing check-ins; Arora Health oversight |
| Shipping | Not verified on captured page | Free overnight, temperature-controlled shipping |
| Refunds/Guarantee | Not captured | 6-month money-back promise; automatic refund if not approved by medical team |
| Regulatory note | Treatment only when a licensed clinician determines it is medically appropriate; compounded meds when offered are not FDA-approved | Compounded medications are not FDA-approved; prepared by state-licensed 503A pharmacies |
How clinical oversight compares
Willow states care is delivered by a licensed telehealth team and that treatment is subject to clinician determination of medical appropriateness. Trimi documents a board-certified medical director and licensed US clinicians through Arora Health, named compounding pharmacies, and offers certificates of analysis on request. Both highlight clinician review; Trimi provides more named details in the captured evidence.
Choosing between Willow and Trimi
Willow vs Trimi comes down to support structure versus price and shipping. Willow emphasizes progress tracking and follow-up consultations as part of a structured weight management journey and notes treatment occurs only when a licensed clinician deems it appropriate. Trimi emphasizes compounded semaglutide and tirzepatide with flat pricing that does not rise with dose adjustments, free overnight shipping, named compounding pharmacies, and a 6-month money-back promise subject to terms.
Visit Trimi for compounding and shipping details
Final guidance
Choose Willow if you want a telehealth-first oral GLP-1 program that prioritizes progress tracking and structured follow-up and when you prefer treatment only after a licensed clinician determines it is medically appropriate. Choose Trimi if you prioritize compounded semaglutide or tirzepatide at lower starting prices on annual plans, flat pricing as dose changes, free overnight shipping, and explicit refund or money-back terms as captured in the source evidence.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →